Please login to the form below

Not currently logged in
Email:
Password:

Evan Lippman joins Aileron Therapeutics

He has experience at EMD Serono, Pfizer and AstraZeneca
Evan Lippman joins Aileron Therapeutics

Aileron Therapeutics has added to its senior team with the appointment of Evan Lippman as its first chief financial and business officer.

The addition comes as the US biopharma prepares to advance its lead oncology candidate ALRN-6924 into clinical trials.

In Lippman Aileron gains the expertise of a man with great experience in life sciences. Most recently Lippman help a senior VP role at EMD Serono heading the strategy for its US neurology franchise.

Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development at the same company.

Lippman's other big pahrma experience includes a period at Pfizer as executive director, worldwide business development and strategic planning.

12th January 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics